EconTalk Vinay Prasad on the Pandemic
Jul 18, 2022
Dr. Vinay Prasad, an oncologist and epidemiologist at UCSF, dives into the complexities surrounding COVID-19 policies. He examines whether the risks of vaccines, like myocarditis in young males, outweigh the benefits. The discussion also covers the nuances of natural versus vaccine-induced immunity and the effectiveness of lockdowns and mask mandates. Prasad critiques the FDA approvals for children’s vaccinations and reflects on the broader implications for children's well-being during the pandemic. His insights challenge preconceived notions, emphasizing the importance of data-driven decisions.
AI Snips
Chapters
Books
Transcript
Episode notes
Russ Roberts' COVID-19 Experience
- Russ Roberts shares his experience of getting COVID-19 despite being triple-vaccinated.
- He questions the necessity of a fourth dose given his age and health status.
Vaccine Effectiveness and Diminishing Returns
- Vaccines effectively reduce severe disease and hospitalization, especially for older, frailer individuals.
- However, the benefits diminish with younger age groups and additional doses, raising questions about their overall value.
Myocarditis: A Serious Side Effect
- Myocarditis is a serious side effect of mRNA vaccines, especially in young men.
- Weighing the risk of myocarditis against the reduced risk of hospitalization is crucial when considering additional doses.
